Related Experiment Video
Updated: Apr 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[ISRAELI GUIDELINES FOR THE TREATMENT OF HYPERLIPIDEMIA - 2014 UPDATE]
Insights
This document updates clinical guidelines for managing atherosclerosis, a major cause of death, in Israel. Recommendations incorporate new research and international standards tailored to the Israeli healthcare system.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Clinical Practice Guidelines
Context:
- Atherosclerosis is a primary global cause of illness and death, significantly impacting Israel.
- Existing clinical recommendations from 2012 require updating due to recent scientific advancements.
- International guidelines, such as the 2013 ACC/AHA Guideline, provide a basis for revised approaches.
Purpose:
- To update the 2012 clinical recommendations for atherosclerosis management in Israel.
- To integrate findings from recent studies and international guidelines.
- To provide practical, evidence-based guidance relevant to the Israeli medical context.
Summary:
- The updated recommendations address the prevention and treatment of atherosclerosis.
- Key updates reflect new understandings of blood cholesterol management for reducing cardiovascular risk.
- Consideration is given to the unique aspects of the Israeli healthcare system.
Impact:
- Aims to improve patient outcomes by optimizing atherosclerosis care in Israel.
- Facilitates evidence-based decision-making for healthcare professionals.
- Contributes to reducing the morbidity and mortality associated with atherosclerotic diseases nationwide.
Abstract:
Atherosclerosis is one of the leading causes of morbidity and mortality in the world, including in Israel. This document updates the clinical recommendations of the Israeli medical societies (The Society for Research, Prevention and Treatment of Atherosclerosis, The Israel Heart Society, The Israel Association of Family Physicians, The Israel Society of Internal Medicine) from 2012. The need for an update stems from new studies and from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. These recommendations take into account the guidelines of leading medical organizations in the world, as well as the specific circumstances and needs of the medical system in Israel.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

